Back to results
US 11,110,303 B2Granted
Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy
OwnerBaofa Yuinventor
Life of this patent
Estimating the term…
Abstract
Embodiments disclosed herein provide methods for treating neoplasm in a mammal, comprising intratumorally administering to the neoplasm an effective amount of a pharmaceutical composition comprising: a hapten; and a redox agent, whereby the neoplasm is treated.
Claims17
A method for treating neoplasm in a mammal, comprising multiple treatments, wherein each treatment comprises intratumorally administering to the neoplasm an effective amount of a pharmaceutical composition comprising:
- a redox agent;
- a hapten;
- and
- at least two chemotherapeutic agents,
- wherein a different hapten is used in each treatment, and
- wherein a first treatment uses 2,4-dinitrophenol (DNP) as a first hapten, a second treatment uses Benzylpenicillin as a second hapten, a third treatment uses Procainamide Hydrochloride as a third hapten, and a fourth treatment uses Hydralazine Hydrochloride as a fourth hapten.
3 more elements
Dependencies are inferred from the claim text.